Summaries for patients. Safety of surgery during bridging anticoagulation therapy with low-molecular-weight heparin.
D000368:Aged; D000925:Anticoagulants / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics*; D004334:Drug Administration Schedule; D017984:Enoxaparin / Q000008:administration & dosage* / Q000009:adverse effects / Q000493:pharmacokinetics*; D015951:Factor Xa / Q000378:metabolism; D005260:Female; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D008297:Male; D008875:Middle Aged; D011300:Preoperative Care / Q000379:methods*; D012307:Risk Factors; D013923:Thromboembolism / Q000139:chemically induced; D014859:Warfarin / Q000627:therapeutic use; D028761:Withholding Treatment
D000925:Anticoagulants; D017984:Enoxaparin; D014859:Warfarin; D015951:Factor Xa